Joshua Barer

Barer & Son Capital LLC (Barer & Son Capital) is a venture capital firm founded in 2017 by Sol Barer. The firm is headquartered in Mendham, New Jersey.

AsclepiX Therapeutics LLC engages in biologics and drug development technology. It specializes in anti-angiogenesis therapy, ophthalmology, oncology, and immunology. The company was founded by Jordan J. Green and Aleksander S. Popel and is headquartered in Baltimore, MD.

Israel Biotech Fund (Israel Biotech) is a venture capital firm founded in 2015 by Yuval Cabilly, David Sidransky, and Gidon Zairi. The firm is headquartered in Rehovot, Israel.

Hibiscus Capital Management (Hibiscus Capital) is a venture capital subsidiary of Hibiscus BioVentures LLC. The firm is headquartered in Delaware.

Trickle Up Program, Inc. is an organization that aims to end extreme poverty by partnering with women. The non-profit company is based in New York, NY. The company believes that women are agents of change and key to breaking the intergenerational cycle of poverty. The organization invests in women and provides them with training and mentoring to build sustainable livelihoods and transform their futures. Trickle Up has reached many lives since 1979 and supports savings groups. The company works through partners and provide coaching in displaced contexts.

The Trout Group LLC is an investor relations and strategic advisory firm exclusively serving the life sciences industry. Since 1995, they have been providing companies in the sector with access to the U.S. institutional investment community. Trout is headquartered in New York and has additional offices in Waltham, Massachusetts and San Francisco.

Founded in 2002, Maxim Group LLC is a registered broker/dealer located in New York City. The firm provides an array of financial services including: investment banking, equity research, private wealth management, structured products and global institutional equity, fixed-income and derivative sales and trading to a diverse range of corporate clients, institutional investors and high net-worth individuals. Maxim Group's niche is emerging-growth companies in a variety of sectors including healthcare, technology, retail and others. They utilize a fundamental, bottom-up approach to investment recommendations. The firm combines rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. The firm focuses on under-covered, small- to-mid-cap companies where valuation levels may be out of sync with fundamental trends. Maxim's coverage universe often represents attractive niche industries where stocks tend to be inefficient. This research coverage fills a void created by the downsized research ranks and shrinking coverage of small- to mid-cap stocks by large investment banks. Maxim Group is a member of FINRA, the MSRB, the SIPC, the ISE, NASDAQ and NYSE Arca.